Rafa Laboratories Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Rafa Laboratories Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10894
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rafa Laboratories Ltd (Rafa) is a pharmaceutical company that manufactures and distributes medicines and consumer health products. The company offers prescription, over-the-counter medicines, proprietary formulations, generic formulations and consumer health products. It offers scale-up and commercial manufacturing capabilities, logistics and storage services, dedicated tech transfer, quality assurance and quality control, and packaging, labeling and distribution. Rafa offers medicines for newborns to aging adults. The company offers medicines in areas of pain, palliative care, gastrointestinal, respiratory, dermatology, psychiatry and consumer health. It operates through its manufacturing facilities and distribution network across Israel. Rafa is headquartered in Jerusalem, Israel.

Rafa Laboratories Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
AXIM Biotech Enters into Distribution Agreement with Rafa Labs 10
Licensing Agreements 11
Rafa Labs Enters into Licensing Agreement with Aeterna Zentaris 11
OSE Pharma Enters into Licensing Agreement with RAFA Labs 12
Rafa Laboratories Ltd – Key Competitors 13
Rafa Laboratories Ltd – Key Employees 14
Rafa Laboratories Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rafa Laboratories Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AXIM Biotech Enters into Distribution Agreement with Rafa Labs 10
Rafa Labs Enters into Licensing Agreement with Aeterna Zentaris 11
OSE Pharma Enters into Licensing Agreement with RAFA Labs 12
Rafa Laboratories Ltd, Key Competitors 13
Rafa Laboratories Ltd, Key Employees 14
Rafa Laboratories Ltd, Other Locations 15

List of Figures
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Rafa Laboratories Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adaptimmune Therapeutics Plc (ADAP):製薬・医療:M&Aディール及び事業提携情報
    Summary Adaptimmune Therapeutics Plc (Adaptimmune), formerly Adaptimmune Therapeutics Limited, is a clinical stage biopharmaceutical company that develops innovative T-cell therapy products for the treatment of cancer. It harnesses the proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) …
  • OnKure Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OnKure Inc (OnKure) is a drug developer that discovers and develops epigenetic therapies for the treatment of cancer. The company offers production of specific histone deacetylases inhibitors. Its lead product candidate ONK102 significantly reduces the growth rate of tumors in hematological …
  • Schmack Biogas GmbH:企業の戦略的SWOT分析
    Schmack Biogas GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Almaty International Airport JSC:企業の戦略・SWOT・財務分析
    Almaty International Airport JSC - Strategy, SWOT and Corporate Finance Report Summary Almaty International Airport JSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Sequana Medical AG:医療機器:M&Aディール及び事業提携情報
    Summary Sequana Medical AG (Sequana Medical), formerly NovaShunt AG, is a commercial stage medical device company that offers automated implantable pump systems to monitor fluid balance within the body. The company designs, develops and commercializes alfapump, a fully implantable, programmable, tra …
  • Andorra Banc Agricol Reig SA:企業の戦略・SWOT・財務情報
    Andorra Banc Agricol Reig SA - Strategy, SWOT and Corporate Finance Report Summary Andorra Banc Agricol Reig SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Berkshire Hills Bancorp, Inc.:企業のM&A・事業提携・投資動向
    Berkshire Hills Bancorp, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Berkshire Hills Bancorp, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • NovoCure Ltd (NVCR)-医療機器分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • Okamura Corporation:企業の戦略・SWOT・財務情報
    Okamura Corporation - Strategy, SWOT and Corporate Finance Report Summary Okamura Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sun Hydraulics Corporation:企業の戦略・SWOT・財務情報
    Sun Hydraulics Corporation - Strategy, SWOT and Corporate Finance Report Summary Sun Hydraulics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Hitachi Zosen Corp (7004):企業の財務・戦略的SWOT分析
    Hitachi Zosen Corp (7004) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Advantest Corporation (6857):企業の財務・戦略的SWOT分析
    Advantest Corporation (6857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • FirstEnergy Corp:発電所・企業SWOT分析
    FirstEnergy Corp - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Life Healthcare Group Holdings Ltd (LHC):企業の財務・戦略的SWOT分析
    Life Healthcare Group Holdings Ltd (LHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Franklin Street Properties Corp:企業の戦略・SWOT・財務分析
    Franklin Street Properties Corp - Strategy, SWOT and Corporate Finance Report Summary Franklin Street Properties Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Chori Co Ltd (8014):企業の財務・戦略的SWOT分析
    Chori Co Ltd (8014) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sichuan Kelun Pharmaceutical Co Ltd (002422)-製薬・医療分野:企業M&A・提携分析
    Summary Sichuan Kelun Pharmaceutical Co Ltd (Kelun) is a pharmaceutical company that manufactures and distributes IV Solutions. The company’s products include mannitol injection, glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’ …
  • Mahindra & Mahindra Limited:企業の戦略・SWOT・財務情報
    Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Halt Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Halt Medical Inc (Halt Medical) is a healthcare service center that develops, manufactures and commercializes medical treatment for women with symptomatic uterine fibroids. The center offers Acessa System, a minimally invasive laparoscopic outpatient procedure to treat uterine fibroids. It o …
  • Fnm Spa:企業の戦略・SWOT・財務分析
    Fnm Spa - Strategy, SWOT and Corporate Finance Report Summary Fnm Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆